Study: Clinical evidence review for Cannabidiol
This 2024 paper is a narrative review of cannabidiol, cannabis-derived products, regulation, pharmacology, and clinical use. It offers a useful overview of why purified CBD, commercial extracts, and broader cannabis products should not be treated as…
Innovative Aptamer-Based Liquid Sensing Display for Label-Free Detection
This study introduces an aptamer-based liquid sensing display for label-free THC detection. The technology integrates with smartphones for rapid, point-of-care analysis. Aptamer-based liquid sensing display offers a novel approach to illicit substance…
Letter by Wu et al Regarding Article, “G Protein-Coupled Receptor Kinase 3 Exacerbates Diabetic Heart Injuries Through Direct Phosphorylation of Cannabinoid Receptor 2 in Humans and Mice”.
This letter discusses cannabinoid receptor 2 phosphorylation and its role in diabetic heart injury. The phosphorylation by GRK3 may impair CB2 receptor function in diabetes. Understanding cannabinoid receptor 2 phosphorylation is key to future diabetic…
Study: Cannabis Harm Reduction Strategies
This 2025 review maps cannabis harm reduction strategies across legal, social, and health-related domains, from packaging rules and driving policies to cannabis social clubs and product testing. It is useful as a typology and policy overview, but it does…
Cannabis Use Disorder Treatment Europe Review
CED Clinical Relevance #50 Monitored Relevance Early-stage or contextual signal requiring further evidence before action. ? Clinical Insight | CED Clinic Evidence Watch Cannabis Use Disorder Europe Mental Health Audience Patients, caregivers,…
What Works—and What Doesn’t—When CVS and CHS Attacks Strike at Home or in the ER
This 2025 clinical review details abortive therapy cyclic vomiting syndrome home ER approaches, synthesizing pharmacologic and non-pharmacologic strategies. It highlights the importance of early intervention during the prodromal phase for CVS and CHS…
Survey of 47 Trials Maps Cannabinoid Research in Neurology—But Evidence Gaps Remain Large
This review maps cannabinoid clinical trials neurology, highlighting 47 completed studies focused on conditions such as Multiple Sclerosis and Fibromyalgia. It reveals significant evidence gaps due to non-standardized protocols and outcome measures. The…
Cannabis and Mental Health: Why ‘Cannabis’ and ‘d9-THC’ Are Not the Same
Cannabis mental health risk factors depend heavily on cannabinoid exposure, especially THC and CBD ratios. Understanding these factors is essential for assessing psychiatric outcomes. This article clarifies why cannabis and d9-THC are not interchangeable…
Cannabis Legalisation Linked to More Adult Use and Increased Acute Harms, Review Finds
This review highlights the cannabis legalisation public health impact, showing increased adult use and acute harms. Pediatric poisonings rose sharply after edibles became available. Adolescent use trends remain mixed, with long-term effects still unclear.
Mobile App-Based Study of Driving Behaviors Under Cannabis Influence
This study investigates cannabis driving impairment using smartphone sensors to detect real-world driving behavior changes. It highlights key impairment indicators such as weaving, wide turning, and hard braking. The findings provide early-stage evidence…